Overview

Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe

Status:
Completed

Trial end date:
2017-08-01

Target enrollment:

Participant gender:

Summary

The primary objective of the study is to compare, in patients treated with methotrexate injection for rheumatoid arthritis, the compliance and the health assessment questionnaire evolution for the administration by auto-injector versus administration by conventional subcutaneous injection, after 6 months of treatment.

Phase:

Phase 3

Details

Lead Sponsor:

GECEM
Nordic Pharma SAS

Treatments:

Methotrexate